Form 4: Edwards Lifesciences CFO Scott Ullem Reports Stock Option Grant and RSU Acquisition

Scott Ullem, CFO of Edwards Lifesciences, reports the acquisition of stock options and restricted stock units (RSUs) and the disposition of shares to cover tax obligations.

Summary

• On May 7, 2024, Scott Ullem, the Chief Financial Officer of Edwards Lifesciences, reported transactions involving the company's stock.
• Ullem acquired 11,075 shares of common stock through restricted stock units (RSUs) granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program.
• He also disposed of 790 shares of common stock to satisfy tax obligations at a price of $85.09 per share.
• Following these transactions, Ullem directly owns 31,759 shares of common stock and indirectly owns 266,318 shares through a trust.
• Ullem was also granted options to acquire 65,500 shares of common stock at an exercise price of $85.84, which become exercisable in monthly installments starting June 7, 2024, and expire on May 6, 2031.
• Additionally, Ullem received performance rights for 11,075 shares, which will vest on May 7, 2027, depending on the achievement of certain performance goals.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine insider transactions related to executive compensation. There are no indications of significant positive or negative events.

Positives

• The grant of stock options and restricted stock units to the CFO aligns his interests with those of the shareholders.
• The vesting schedule of the options and RSUs encourages long-term performance and retention.

Negatives

• The disposal of shares to cover tax obligations, while common, slightly reduces the CFO's direct holdings in the company.

Risks

• The vesting of performance rights is contingent upon achieving certain performance goals, which may not be met.
• Fluctuations in the stock price could impact the value of the stock options and RSUs.

Future Outlook

The document outlines the vesting schedules for the granted RSUs, stock options, and performance rights, indicating future potential equity ownership for the reporting person based on continued employment and performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the equity ownership and compensation structure of key executives.

Stakeholder Impact

• The transactions reported may have a minor impact on shareholders due to the change in beneficial ownership.
• The equity-based compensation structure can motivate the CFO to drive company performance, benefiting shareholders in the long run.

Key Dates